Trial Profile
A Two Part Study to Assess the Pharmacodynamic Effects of Unfractionated Heparin (UFH) in Healthy Volunteers and the Effects of Bendavia(TM) and Unfractionated Heparin When Administered Concurrently
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Elamipretide (Primary) ; Heparin
- Indications Blood coagulation disorders; Deep vein thrombosis; Diabetes mellitus; Eye disorders; Kidney disorders; Neurodegenerative disorders; Reperfusion injury
- Focus Pharmacodynamics
- Sponsors Stealth Peptides
- 18 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 25 Jan 2012 New trial record